Newly Diagnosed
Drug | Drug Name | Drug Description |
---|---|---|
DB05812 | Abiraterone | An antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer. |
DB01169 | Arsenic trioxide | A chemotherapeutic agent used in the treatment of refractory or relapsed acute promyelocytic leukemia in patients with prior retinoid and anthracycline chemotherapy. |
DB06616 | Bosutinib | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. |
DB00987 | Cytarabine | A pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. |
DB09331 | Daratumumab | A CD38-directed cytolytic antibody used alone or as an adjunct drug in the treatment of multiple myeloma and light chain amyloidosis. |
DB01254 | Dasatinib | A tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia. |
DB00694 | Daunorubicin | An anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia. |
DB00056 | Gemtuzumab ozogamicin | A monoclonal anti-CD33 antibody used to treat CD33-positive acute myeloid leukemia. |
DB14568 | Ivosidenib | An isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation. |
DB11581 | Venetoclax | A BCL-2 inhibitor used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11942 | Selinexor | 1 | Active Not Recruiting | 1 |
DB00853 | Temozolomide | 1 | Active Not Recruiting | 1 |
DB11617 | Aclarubicin | 2 | Not Yet Recruiting | 1 |
DB00928 | Azacitidine | 2 | Recruiting | 1 |
DB06769 | Bendamustine | 2 | Not Yet Recruiting | 1 |
DB09052 | Blinatumomab | 2 | Completed | 1 |
DB00188 | Bortezomib | 2 | Recruiting | 1 |
DB16741 | Bortezomib D-mannitol | 2 | Recruiting | 1 |
DB00242 | Cladribine | 2 | Not Yet Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Not Yet Recruiting | 1 |
DB00987 | Cytarabine | 2 | Not Yet Recruiting | 1 |
DB01234 | Dexamethasone | 2 | Recruiting | 1 |
DB00099 | Filgrastim | 2 | Not Yet Recruiting | 1 |
DB01073 | Fludarabine | 2 | Not Yet Recruiting | 1 |
DB00480 | Lenalidomide | 2 | Recruiting | 1 |
DB08901 | Ponatinib | 2 | Suspended | 1 |
DB00073 | Rituximab | 2 | Not Yet Recruiting | 1 |
DB06334 | Tucidinostat | 2 | Recruiting | 1 |
DB11581 | Venetoclax | 2 | Recruiting | 1 |
DB15035 | Zanubrutinib | 2 | Not Yet Recruiting | 1 |
DB09035 | Nivolumab | 3 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 3 | Active Not Recruiting | 1 |
DB12332 | Rucaparib | 3 | Active Not Recruiting | 1 |
DB00188 | Bortezomib | Not Available | Not Yet Recruiting | 1 |
DB08889 | Carfilzomib | Not Available | Not Yet Recruiting | 1 |
DB09331 | Daratumumab | Not Available | Active Not Recruiting | 1 |
DB09331 | Daratumumab | Not Available | Not Yet Recruiting | 1 |
DB01234 | Dexamethasone | Not Available | Not Yet Recruiting | 1 |
DB01276 | Exenatide | Not Available | Completed | 1 |
DB00619 | Imatinib | Not Available | Completed | 1 |
DB00030 | Insulin human | Not Available | Completed | 1 |
DB00046 | Insulin lispro | Not Available | Completed | 1 |
DB00480 | Lenalidomide | Not Available | Not Yet Recruiting | 1 |
DB14123 | Menthol | Not Available | Not Yet Recruiting | 1 |
DB01132 | Pioglitazone | Not Available | Completed | 1 |
DB13700 | Protamine | Not Available | Completed | 1 |
DB01593 | Zinc | Not Available | Completed | 1 |